PANGEN Biotech is engaged in the production and sale of biosimilar EPO pharmaceuticals, contract manufacturing (including preclinical and clinical samples), development technology transfer services, and biopharmaceutical development. On August 25, 2023, the company announced the approval of Fanpotin Prefilled Syringe 6000IU and 10000IU, an anemia treatment, and plans to apply for product approval in other countries as well.

PANGEN CHO_TECH : Producuer cell line development / manufacturing process development / Scale up technology / GMP operation and management

Public

Biotech